Abstract
The chromosome passenger complex (CPC) is composed of five proteins: Aurora B kinase, Borealin, INCENP, Survivin and TD-60. CPC functions as an oligo-enzyme, each member activating the catalytic subunit, Aurora B kinase. CPC controls chromosome congression, bidirectional tension on kinetochores and spindle checkpoint signalling as well as cytokinesis completion. CPC is thus a key regulator during mitosis; CPC proteins are exclusively expressed during mitosis and are up-regulated in many tumours. Their overexpression correlates with the level of genomic instability within tumours. Altogether, this leads to the proposal of passenger proteins as potential targets for cancer therapy. This review describes the chromosomal passenger complex and its involvement in mitosis and the different strategies developed towards its inactivation.
Keywords: Aurora kinase, survivin, borealin, INCENP, passenger proteins, cancer therapy, mitosis, kinase inhibitors, chromosome passenger complex
Current Enzyme Inhibition
Title: Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy
Volume: 4 Issue: 3
Author(s): Thi My Nhung Hoang, Marlene Delacour-Larose and Annie Molla
Affiliation:
Keywords: Aurora kinase, survivin, borealin, INCENP, passenger proteins, cancer therapy, mitosis, kinase inhibitors, chromosome passenger complex
Abstract: The chromosome passenger complex (CPC) is composed of five proteins: Aurora B kinase, Borealin, INCENP, Survivin and TD-60. CPC functions as an oligo-enzyme, each member activating the catalytic subunit, Aurora B kinase. CPC controls chromosome congression, bidirectional tension on kinetochores and spindle checkpoint signalling as well as cytokinesis completion. CPC is thus a key regulator during mitosis; CPC proteins are exclusively expressed during mitosis and are up-regulated in many tumours. Their overexpression correlates with the level of genomic instability within tumours. Altogether, this leads to the proposal of passenger proteins as potential targets for cancer therapy. This review describes the chromosomal passenger complex and its involvement in mitosis and the different strategies developed towards its inactivation.
Export Options
About this article
Cite this article as:
Nhung Hoang My Thi, Delacour-Larose Marlene and Molla Annie, Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy, Current Enzyme Inhibition 2008; 4 (3) . https://dx.doi.org/10.2174/157340808785909402
DOI https://dx.doi.org/10.2174/157340808785909402 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pulmonary Arterial Hypertension
Current Vascular Pharmacology In vitro Measurement and In vivo Prediction of Time-Dependent Inhibitory Effects of Three Tyrosine Kinase Inhibitors on CYP3A Activity
Current Drug Metabolism Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders
Current Pharmaceutical Design Regulation and Function of DNA and Histone Methylations
Current Pharmaceutical Design Therapeutic Strategy of Advanced Hepatocellular Carcinoma by Using Combined Intra-Arterial Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery L1 Retrotransposon and Retinoblastoma: Molecular Linkages Between Epigenetics and Cancer
Current Molecular Medicine The Need for Diagnostic Criteria in Systemic Vasculitis
Current Immunology Reviews (Discontinued) miRNAs in Bone Development
Current Genomics Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia
Current Pharmaceutical Design Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
Current Pharmaceutical Design Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Current Cancer Therapy Reviews Mechanism-based Combinations with Pim Kinase Inhibitors in Cancer Treatments
Current Pharmaceutical Design Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates
Current Topics in Medicinal Chemistry Immune Therapy of Multiple Sclerosis - Future Strategies
Current Pharmaceutical Design miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry Personalized Medicine in a Consumer Age
Current Pharmacogenomics and Personalized Medicine Blocking Ca2+ Entry: A Way to Control Cell Proliferation
Current Medicinal Chemistry Stem Cell Defects in Philadelphia Chromosome Negative Chronic Myeloproliferative Disorders: A Phenotypic and Molecular Puzzle?
Current Stem Cell Research & Therapy Current and Emerging Therapeutic Approaches in HCV-Related Mixed Cryoglobulinemia
Current Medicinal Chemistry